- Home
- VCYT vs LGN Comparison
VCYT vs LGN Comparison
Compare VCYT & LGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCYT
- LGN
- Stock Information
- Founded
- VCYT 2006
- LGN 1963
- Country
- VCYT United States
- LGN United States
- Employees
- VCYT N/A
- LGN N/A
- Industry
- VCYT Medical Specialities
- LGN
- Sector
- VCYT Health Care
- LGN
- Exchange
- VCYT Nasdaq
- LGN Nasdaq
- Market Cap
- VCYT 2.6B
- LGN 3.1B
- IPO Year
- VCYT 2013
- LGN 2025
- Fundamental
- Price
- VCYT $34.84
- LGN $31.72
- Analyst Decision
- VCYT Buy
- LGN Strong Buy
- Analyst Count
- VCYT 9
- LGN 10
- Target Price
- VCYT $39.89
- LGN $37.55
- AVG Volume (30 Days)
- VCYT 895.7K
- LGN 1.7M
- Earning Date
- VCYT 11-05-2025
- LGN 01-01-0001
- Dividend Yield
- VCYT N/A
- LGN N/A
- EPS Growth
- VCYT N/A
- LGN N/A
- EPS
- VCYT 0.34
- LGN N/A
- Revenue
- VCYT $479,129,000.00
- LGN $2,213,862,000.00
- Revenue This Year
- VCYT $14.48
- LGN N/A
- Revenue Next Year
- VCYT $9.79
- LGN N/A
- P/E Ratio
- VCYT $102.86
- LGN N/A
- Revenue Growth
- VCYT 19.91
- LGN 77.61
- 52 Week Low
- VCYT $22.61
- LGN $26.96
- 52 Week High
- VCYT $47.32
- LGN $34.40
- Technical
- Relative Strength Index (RSI)
- VCYT 59.94
- LGN N/A
- Support Level
- VCYT $31.81
- LGN N/A
- Resistance Level
- VCYT $36.85
- LGN N/A
- Average True Range (ATR)
- VCYT 1.40
- LGN 0.00
- MACD
- VCYT 0.06
- LGN 0.00
- Stochastic Oscillator
- VCYT 60.91
- LGN 0.00
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.